glp-1 receptor agonist and dpp-4 inhibitor combination contraindicated Clinical Use of Inhibitors GLP-1 receptor agonist versus DPP-4
Description
References 1.Wen S., Nguyen T., Gong M., Yuan X., Wang C., Jin J., Zhou L
rskov, C., Holst, J
S.JangS
doi: 10.1093/cvr/cvac013 [DOI] [PubMed] [Google Scholar] 62
For individuals prescribed GLP-1 receptor agonists as part of a comprehensive diabetes or obesity management plan, incorporating allulose as a sugar substitute could support treatment goals without compromising palatability
